However, in PD without using Levodopa group, though the sample was small we also try to analyze, and the results showed that the cTfh cells was still higher than HCs (P = 0.044, Figure 6E), the percentage of CD19+ B cells among PBMCs was no obvious difference (P = 0.978, Figure 6F). This evidence concerns the gene CD19 and Parkinson disease.